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11 1. INTRODUCTION 
2 Dry eye disease (DED) understanding has grown over the last three decades. 
3 This multifactorial disorder is characterised by a loss of homeostasis of the tear 
4 film and accompanied by ocular symptoms, neurosensory abnormalities, ocular 
5 surface inflammation and damage.[1] DED prevalence ranges between 5% and 
6 50% worldwide[2] and it increases linearly with age which makes DED a growing 
7 public health issue as the global population of older people is expected to be 
8 more than double its current amount by 2050.[3] According to TFOS DEWS II 
9 DED classification, the aqueous deficiency (ADDE) and evaporative dry eye 
10 (EDE) are the two major types of DED and are considered to exist on a continuum 
11 rather than as separate entities.[4] It has been reported that the evaporative 
12 component is more common, making EDE the most common type of DED.[2] 
13 Meibomian gland dysfunction (MGD) has been considered the major cause of 
14 EDE.[5] Changes in the quantity and quality of the meibomian gland (MG) 
15 secretion lead to an unstable lipid layer of the tear film, provoking an increase of 
16 the evaporation of the underlying aqueous layer.[6] Therefore, any change that 
17 occurs in the structure or function of MG could have an important clinical impact. 
18 Currently, non-contact infrared meibography (NIM) is widely used to assess MG 
19 non-invasively[7–9]. Several scoring systems for assessment of the meibomian 
20 gland loss (MGL) or dropout [7,10–14]have been proposed. The meiboscore 
21 proposed by Arita et al. [7] is one of the most commonly used scoring system for 
22 MGL evaluation. Previous studies found significant correlations between MGL 
23 and some tear film parameters (such as tear film break-up time (TBUT) [15–17], 
24 non-invasive tear film break-up time (NIBUT), [18] lipid layer thickness (LLT) [19], 
25 Schirmer test [20], MG secretion quality [16] and corneal staining [17]) as well as 
226 subjective symptomatology (Ocular Surface Disease Index (OSDI) [10] and 
27 Mcmonnies [21] questionnaires), suggesting its possible diagnostic value.[22] 
28 However, others studies concluded that assessing MGL alone as clinical 
29 parameter has not enough DED diagnostic value, and that it should be interpreted 
30 together with other clinical parameters.[16,23,24] Furthermore, it has been well-
31 documented that MGL increases with age in both healthy subjects [7,15,25] and 
32 DED patients.[26] Indeed, a significant positive correlation between age and MGL 
33 was detected, indicating that the number of MG decreases with age.[7] On the 
34 other hand, in a previous study it has been observed that several ocular surface 
35 parameters such as ocular redness, corneal and conjunctival staining are highly 
36 influenced by ageing.[27] As well, TFOS DEWS II recently underlined that clinical 
37 DED signs increase in a higher amount by decade compared with symptoms.[2] 
38 These findings highlight the role of age in both MGL and ocular surface 
39 parameters. Thus, the aim of this prospective study was to assess the 
40 relationship between MGL and ocular surface parameters and the role of age on 
41 its relationship.   
42
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347 2. MATERIAL AND METHODS
48 2.1 Participants
49 One-hundred sixty-one participants were included in this prospective study. 
50 Participants were recruited via email notices sent to the institutional e-mails from 
51 the academic community and advertisements placed on noticeboards at the 
52 university. All examinations were completed in the Faculty of Optics and 
53 Optometry at Complutense University of Madrid. This study was reviewed and 
54 approved by the Ethics Committee of San Carlos University Hospital (Madrid, 
55 Spain) and adhered to the tenets of the Declaration of Helsinki. Written informed 
56 consent was obtained from all included participants after explanation of the 
57 purpose and possible consequences of the study. Participants were required to 
58 be 18 years of age or older, be able to complete the questionnaires, understand 
59 the procedures and an obtain an evaluable meibography image of the upper (UL) 
60 and lower (LL) eyelids. On the other hand, participants were excluded if they had 
61 a history of any active ocular disease different from DED and MGD (corneal 
62 ulcers, herpes simplex, keratitis...), any uncontrolled severe systemic disease 
63 that may affected the eye (Sjögren syndrome, diabetes type II, dermatological 
64 diseases…) or any ocular surgery or trauma that could affect the tear distribution 
65 and any eyelid margin abnormality. Contact lens wearers were accepted but they 
66 were required not to use their contact lenses within the week before performing 
67 the clinical examination.
68 2.2 Study Protocol
69 All measurements were accomplished by the same examiner and performed from 
70 the least to the most invasive in order to minimize the effect of the previous 
471 measurement. Only the right eye (RE) of each participant was assessed (see 
72 Figure 1). 
73 2.2.1 Symptomatology Assessment
74 Participants were required to complete two of the most common DED 
75 Questionnaires during the examination: The OSDI questionnaire [28] and the 
76 Standard Patient Evaluation of Eye Dryness (SPEED) questionnaire.[29]
77 2.2.2 Tear Film Osmolarity
78 Tear film osmolarity (TFO) was measured using the TearLab Osmolarity System 
79 (TearLab Corp, San Diego, CA, USA) according to the manufacturer’s 
80 instructions. It was conducted in first place in order to avoid reflex tearing or the 
81 instillation of any dye that could affect the results. 
82 2.2.3 Keratograph 5M Automated Measurements
83 Automated measurements were performed using the Keratograph 5M (K5M; 
84 Oculus GmbH, Wetzlar, Germany) equipped with the modified tear film scanning 
85 function. Three measurements of the tear meniscus height (TMHk), first tear film 
86 break-up time (NIKBUT-fr), the average time of all tear film break-up time 
87 incidents (NIKBUT-avg), bulbar redness (BR) and limbal redness (LR) were 
88 obtained automatically with Oculus K5M software according to the 
89 manufacturer’s instructions. 
90 2.2.4 Slit-Lamp Examination
91 Slit-lamp examination of the cornea and conjunctiva was performed under diffuse 
92 illumination using x10 – x16 magnification. Corneal integrity was assessed by 
93 instilling a fluorescein dye. Two minutes later, corneal staining was graded using 
94 the Oxford scoring scheme.[30] TBUT was measured three times with a 
595 stopwatch and was averaged for the subsequent analysis. Furthermore, bulbar 
96 conjunctival integrity was assessed using lissamine green and graded using the 
97 Oxford scoring scheme. [30] The meibum quality expression from the central 8 
98 MG was assessed on a scale from 0 to 3: 0 = clear meibum readily expressed; 
99 1= cloudy meibum expressed with mild pressure; 2=cloudy meibum expressed 
100 with more than moderate pressure; 3= meibum could not be expressed even with 
101 strong pressure. 
102 2.2.5 Keratograph 5M Infrared Meibography
103 NIM was performed in order to assess MG morphology of the UL and LL of each 
104 participant. MGL of the UL and LL was graded subjectively by an experienced 
105 examiner using the meiboscore introduced by Arita et al (grade 0, no gland loss; 
106 grade 1, area of gland loss <33%; grade 2, area of gland loss 33%–67%; and 
107 grade 3, area of gland loss >67%). [7] The meiboscore for each eyelid was 
108 summed to give a total score between 0 and 6 (or from 0 to 6). This total 
109 meiboscore was used to divide participants into five groups according with the 
110 amount of MGL (see Figure 2). In this regard, the group 1 was constituted by 
111 participants who presented a total meiboscore of 0; group 2 by participants who 
112 showed a total meiboscore of 1; group 3 by participants who showed a total 
113 meiboscore of 2; group 4 by participants who showed a total meiboscore of 3  
114 and group 5 by participants who showed a total meiboscore of 4,5 or 6. According 
115 the groups established, the percentage range of MGL was 0, 0-16.6, 16.5-33,33-
116 49.5 and >50, for groups 1, 2, 3, 4 and 5 respectively.
117 2.2.6 Tear Film Volume 
118 Schirmer’s test was performed with topical anaesthesia (Colirio Anestésico 
119 Doble®, Alcon Laboratories, Spain) and was the final test carried out in the 
6120 examination protocol. One drop of topical anaesthesia was instilled on the 
121 conjunctival lower fornix of the RE, 5 minutes prior to do the test. Then, the 
122 Schirmer strip (35-mm Whatman filter paper; Tiedra Laboratories, Spain) was 
123 placed in the lower conjunctival sac at the junction of the lateral and middle thirds 
124 (avoiding contact with the cornea) and after 5 minutes the length of wetting was 
125 recorded. Participants were seated at rest and were asked to close the eyes 
126 during the test.
127 2.3 Data Analysis
128 The values are expressed as means ± standard deviation (SD) and the 
129 significance level was set p< 0.05 with 95% of confidence level. Normality of the 
130 data distribution was tested using the Kolmogorov–Smirnov test. Accordingly, 
131 Cohen’s kappa coefficient (weighted kappa value- 95% of confidence) was 
132 calculated and classified as follow: 0.00(poor), 0.00-0.20 (slight), 0.21-0.40 (fair), 
133 0.41-0.60 (moderate),0.61-0.80(substantial) and 0.80-1.0 (close to perfect) [31]. 
134 Kruskal–Wallis test was used for comparisons between different MGL groups.  
135 When statistically significant differences were found (p<0.05), post hoc tests were 
136 performed for multiple comparisons applying Bonferroni corrections. Correlation 
137 coefficients between MGL of both eyelids and ocular surface parameters were 
138 calculated with the Spearman correlation coefficient. In addition, partial 
139 correlation was performed including age as a covariant. These correlations were 
140 considered strong if they were >0.80, moderately strong if they were between 0.5 
141 and 0.8, fair if they were within the range of 0.3 and 0.5 and poor if they were < 
142 0.30.[32]
143
144
7145 3. RESULTS
146 The demographic characteristics of the participants are summarized in Table 1. 
147 From the 161 participants 91 were females and 70 males. Age range among 
148 participants was 19 to 88 years with a mean age of 42±17 years.
149 3.1 Association and correlation between UL and LL
150 A contingency table was used to compare MGL between UL and LL (Table 2) in 
151 order to know if it is necessary to evaluate the MGL in one eyelid or in both. 
152 Weighted kappa statistics showed no statistically significant agreement (weighted 
153 k value=0.2; p=0.3; range 0.099-0.353, 95% confidence limit) indicating no 
154 association between both eyelids. Despite it, a fair and statistically significant 
155 correlation was found between UL and LL (Spearman: r= 0.3; p<0.001). For this 
156 reason, both eyelids should be assessed in order to know the overall condition of 
157 MG and its possible influence in the ocular surface state. 
158 Table 3 shows the demographics of the participants as a function of total 
159 Meiboscore.
160 3.2 Symptomatology assessment
161 Results regarding subjective symptomatology are showed in Table 4. No 
162 statistically significant differences were found in OSDI (p=0.3) and SPEED 
163 (p=0.506) questionnaires among different MGL groups.
164 3.3 Classical Clinical Parameters
165 Classical clinical parameters results for each group are shown in Table 5. 
166 Statistically significant differences were found among groups in TFO (p=0.02), 
167 corneal (p=0.01) and conjunctival staining (p=0.004). For TFO, there were 
168 statistically significant differences between group 5 and groups 1,2 and 3 (p=0.02; 
169 p=0.01; p=0.001, respectively). For corneal staining, there were statistically 
8170 significant differences between group 5 and groups 1 and 2 (p=0.04 and 0.003, 
171 respectively). Regarding conjunctival staining, there were also statistically 
172 significant differences between group 5 and groups 1 and 2 (p=0.02 and 0.007, 
173 respectively) and between group 4 and groups 1 and 2 (p= 0.04 and 0.01, 
174 respectively). 
175 3.4 Keratograph 5M Automated Measurements
176 Table 6 shows the automated measurements obtained with K5M for each 
177 meiboscore group. Statistically significant differences in BR were found between 
178 groups 5 and 1 (p=0.04) and groups 5 and 2 (p=0.01). 
179 3.5 Relationship between MGL and ocular surface parameters considering 
180 age as covariant.
181 Partial correlations between MGL and ocular surface parameters are shown in 
182 Table 7. No relationship was found between MGL and any ocular surface 
183 parameter except for corneal staining (r=0.2, p=0.04) when age was included as 
184 covariant.
185
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9194 4. DISCUSSION
195 NIM has been proven to be a useful technique for non-invasive observation of  
196 MG morphology in order to help physicians improve DED diagnosis and 
197 treatments.[7,33,34]
198 The aim of the study is to assess the correlation between MGL and some other 
199 ocular surface parameters. Accordingly, first it has to be determined if both (UL 
200 and LL) or only one eyelid should be included for MGL assessment. This matter 
201 is quite controversial since different studies with different aims have considered 
202 both or only one eyelid. Routinely, LL is the most commonly assessed due to its 
203 accessibility which provokes less discomfort to the patient. It is believed that 
204 comparable outcome can be expected for MGL assessment choosing one or two 
205 eyelids, as UL and LL MGL seem to be significantly correlated.[18] Dogan et al. 
206 [35] assessed meibography images of 30 patients and proposed to evaluate only 
207 the UL for MGL assessment because of its correlation with TBUT and better inter-
208 examiner agreement on MGL. On the other hand, Finis et al. [16] performed a 
209 retrospective analysis of 128 patients and found a strong correlation between 
210 meiboscores of the UL and the LL as well as with the total meiboscore. This 
211 suggests that MGL assessment based on the evaluation of the LL might be 
212 enough for the clinical routine. In the present study a positive and fair statistically 
213 significant correlation between MGL of UL and LL was found. However, there was 
214 no agreement as revealed by the Kappa statistic, suggesting that, despite there 
215 exist a relationship between MGL of both eyelids there is a bias in their 
216 meiboscore. Our results could support those found by Pult et al. [18], who 
217 suggested the assessment the MGL of both eyelids. 
10
218 After concluding that both eyelids should be taken into account in order to assess 
219 MGL, participants were classified into five groups according to the total 
220 meiboscore.[7] 
221 DED symptomatology was evaluated using OSDI and SPEED questionnaires in 
222 the current study. No statistically significant differences were found in DED 
223 questionnaires among different MGL groups. However, as Table 4 shows, the 
224 symptomatology score for group 5, in both questionnaires, is clinically higher than 
225 for the other groups. It has been reported that an MGL of >32% is likely to be 
226 accompanied with associated detectable clinical symptoms.[10] Similarly,  
227 several studies have found correlation between MGL and OSDI scores.[25,36] 
228 On the other hand, other studies have not found any correlation between MGL 
229 and OSDI scores [26,35] or SPEED questionnaire. [37]
230 Regarding MGL and its correlation with other clinical parameters, statistically 
231 significant differences were found in TFO between group 5 and groups 1,2 and 
232 3. Besides, statistically significant differences were found in corneal staining as 
233 well as conjunctival staining between group 5 and groups 1 and 2. These results 
234 are in agreement with those obtained by Feng et al. [26] who found a positive 
235 correlation between corneal staining and MGL in DED patients. Previous studies 
236 have suggested that when the amount of MG reduced, the secretion of MG 
237 decreases. This might induce tear film homeostasis loss and greater tear film 
238 evaporation which could lead to surface epithelial damage, and disturbance of 
239 the glycocalyx and goblet cell mucins.[38] 
240 In the present study no differences were found in TBUT and Schirmer test among 
241 different MGL groups. These results are in accordance with other studies that did 
242 not find any correlation between MGL and these tear film parameters [39] or a 
11
243 low correlation was found.[26] Nevertheless, Arita et al. [40] studied a population 
244 with MGD and found that Schirmer test was positively correlated with the 
245 meiboscore. Thus, patients with less amount or damaged MG would have an 
246 increase of fluid that may compensate the decreased function of the lipid layer. 
247 All these findings together suggest that these ocular surface parameters could 
248 be affected by MGL in patients who suffer from MGD since the glandular loss 
249 may exacerbate the signs of MGD in comparison with those who only present 
250 MGL without other ocular condition.
251 No statistically significant differences were found in any of the 5KM parameters 
252 among MGL groups except for BR. Recently, Ji et al. [41] found a correlation 
253 between MGL grade and NIKBUT-avg, NIKBUT and LLT in patients with DED 
254 and MGD. This discrepancy between studies could due to the population studied. 
255 Indeed, the correlation found might be because they only included subjects with 
256 DED and MGD. 
257 Our findings suggest that a MGL higher than 50% is accompanied by signs of 
258 increased osmolarity, redness and staining of the ocular surface. However, it is 
259 important to highlight that the mean age of the participants in this study was 
260 higher in those groups with higher MGL. Therefore, it is not possible to ascertain 
261 if these signs in ocular surface parameters are due to MGL or to age. Indeed, the 
262 great influence of aging on MG morphology and function is well-known and 
263 documented in the literature [7,18,27,39]. In order to address this point, the 
264 relationship between MGL and the ocular surface parameters was assessed 
265 considering age as a covariant. When it was performed, only the corneal staining 
266 was correlated with MGL. These results emphasize the influence of ageing in the 
267 MG morphology but also in several ocular surface parameters such as corneal 
12
268 staining, LLT or tear volume among others. [27,42] This has been previously 
269 reported [27] and points out the importance of considering participants age when 
270 performing  research studies focused on the ocular surface. Thus, in order to 
271 assess the real impact or influence of the MGL in ocular surface parameters 
272 (which are influenced by age), it would be necessary to compare matched age 
273 groups. For example, MGL has been found to be positively correlated with 
274 meibum quality suggesting an impaired MG function when MGL 
275 increase.[19,41,43] The present study has shown that when age is covariant, the 
276 relationship between MGL and meibum quality is absent, indicating that meibum 
277 quality could be decreased either because a higher amount of MGL or because 
278 it is naturally decreased with aging. These findings suggest that different 
279 thresholds for defining abnormal ocular and tear film surface parameters should 
280 be considered according with the age. Next steps should be focused on 
281 determining the normal values of different parameters for each age range.
282 In summary, this study suggests that a MGL higher than 50% is accompanied by 
283 signs in the ocular surface. As well, in the light of the findings, future studies must 
284 consider age due to its great influence on the MG morphology and compare 
285 matched-age groups in order to know the contribution of the MGL on the ocular 
286 surface as well as establish valid cut-off values for DED diagnosis.
287
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469 FIGURES LEGENDS
470
471 Figure 1. Flow diagram of the study protocol. Numbers indicate the order of 
472 performance of each test (from less invasive towards to the most invasive). 
473 Figure 2. Different grades of MGL in the UL and LL obtained by non-contact 
474 infrared meibography (Oculus Keratograph K5M). A.1 and A.2) Participants 
475 without MGL in the UL and LL (total meiboscore 0; = 0%). B.1 and B.2) 
476 Participants with slight MGL in the UL and LL (total meiboscore 1; < 33%). C.1 
477 and C.2) Participants with moderate MGL in the UL and LL (total meiboscore 2; 
478 33-66%).  D.1 and D.2) Participant with severe MGL in the UL and LL (total 
479 meiboscore 3; >66%).
480
481


Table 1. Demographic data from the participants of the study. Results are 
expressed in mean± standard deviation (SD) for each parameter. 
N 161
 Age
(years)
42±17
Age range
(years)
19 to 88
Male/ Female
(%) 
43/57
OSDI
(scores)
17.47±15.65
SPEED
(scores)
7±5
TFO
(mOsms/L)
309±17
TMHk 
(mm)
0.26±0.08
REDNESS
(scores)
Limbal 0.70±0.37
Bulbar 1.11±0.49
NIKBUT
(seconds)
First 9.05±5.41
Average 12.02±5.26
TBUT
(seconds)
4.36±2.07
SCHIRMER TEST
(mm)
11.83±7.14
OSDI: The Ocular-surface-disease-index; SPEED: Standard Patient Evaluation of Eye Dryness; TFO: tear film osmolarity; 
TMHk: tear meniscus height;  Bulbar and limbal redness were graded automatically by K5M software; NIKBUT-FR: first 
rupture non-invasive Keratograph tear film break-up time; NIKBUT-AVG: average of non-invasive Keratograph tear film 
break-up time. 
Table 2. Contingency table of MGL for UL and LL.
Upper Eyelid
Meiboscore* 0 1 2 3 Row 
Totals 
0 21
44.68%
36.84%
22
46.81%
32.84%
4
8.51%
16.00%
0
0%
0%
47
1 33
39.76%
57.89%
36
43.37%
53.73%
12
14.46%
48.00%
2
2.41%
28.51%
83
2 3
13.04%
5.26%
8
34.78%
11.94%
9
39.13%
36.00%
3
13.04%
42.86%
23
Lower 
Eyelid
3 0
0%
0%
1
33.33%
1.49%
0
0%
0%
2
66.67%
28.57%
3
Column 
Totals 
57 67 25 7 156
UL: Upper eyelid; LL: Lower eyelid; MGL: Meibomian gland loss
*Meiboscore: Grade 0, no gland loss; grade 1, area of gland loss <33% of the total gland area; grade 2, area of gland loss 
33%–67%; and grade 3, area of gland loss >67%
Table 3. Characteristics and distribution of the sample according the MGL grade 
(meiboscore). Results expressed in mean± standard deviation (SD) and 
percentage (%). 
     *The total meiboscore is the sum of the meiboscore of both eyelids (0-6). MGL: Meibomian gland loss
Group 1 Group 2 Group 3 Group 4 Group 5
Total
Meiboscore*
0
(reference)
1 2 3 4+5+6
MGL(%) 0 0-16.5 16.5-33 33-49.5 >50
N (%) 21
(13.04%)
59
(36.65%)
44
(27.33%)
20
(12.42%)
17
(10.55%)
AGE
(years)
34±11 37±15 46±17 50±18 60±18
FEMALE(%)       9/91
9.9%
33/91
36.3%
27/91
29.7%
8/91
8.8%
12/91
13.2%
MALE(%)
     12/70
17.1%
25/70
35.7%
17/70
24.3%
12/70
17.1%
4/70
5.7%
Table 4. Comparison of symptomatology scores among different MGL grades. 
Results expressed in mean± standard deviation (SD) for each parameter (units).
*statistically significant differences among groups; p<0.05.
OSDI: The Ocular-surface-disease-index; SPEED: Standard Patient Evaluation of Eye Dryness. 
TOTAL MEIBOSCORE 
GROUP
(MGL%)
SYMPTOMATOLOGY
OSDI
(scores)
SPEED
(scores)
Group 1
(0)
14.30±13.95 7±5
Group 2
(0-16.5)
16.34±13.90 7±5
Group 3
(16.5-33)
18.30±16.76 7±5
Group 4
(33-49.5)
15.61±15.21 6±5
Group 5
(>50)
23.28±23.28 9±5
p-value 0.385 0.506
Table 5. Comparison of classical clinical parameters among different MGL grades. Results expressed in mean± standard deviation 
(SD) for each parameter (units).
                        
* statistically significant differences among groups; p<0.05.
TFO: tear film osmolarity; TBUT: tear break-up time; Corneal and conjunctival staining were graded using Oxford Staining Score System.
TOTAL MEIBOSCORE 
GROUP
(MGL%)
CLASSICAL CLINICAL PARAMETERS
TFO 
(mOsms/L)
TBUT 
(seconds)
SCHIRMER
(mm)
CORNEAL 
STAINING
(scores)
CONJUNCTIVAL 
STAINING
(scores)
Group 1
 (0)
308±16 4.86±2.52 13±6 0.76±0.70 1.19±0.68
Group 2
 (0-16.5)
309±19 4.85±2.57 13±8 0.62±0.85 1.20±0.83
Group 3
 (16.5-33)
304±15 4.04±1.46 11±7 0.98±0.86 1.67±1.02
Group 4
 (33-49.5)
312±12 3.96±1.22 10±7 0.85±0.67 1.75±0.79
Group 5
 (>50)
326±18 3.64±1.51 11±4 1.47±1.23 1.88±0.93
p-value 0.023* 0.249 0.160 0.015* 0.004*
Table 6. Comparison of K5M automated measurements among different MGL grades. Results expressed in mean± standard deviation 
(SD) for each parameter (units).
TOTAL MEIBOSCORE 
GROUP
(MGL%)
K5M AUTOMATED MEASUREMENTS
TMHk
(mm)
BR
(scores)
LR
(scores)
NIKBUT-first
(seconds)
NIKBUT-avg
(seconds)
Group 1
 (0)
0.23±0.05 1.00±0.46 0.68±0.35 11.23±6.82 13.81±6.15
Group 2
 (0-16.5)
0.26±0.71 0.99±0.44 0.62±0.32 8.79±5.12 11.80±5.02
Group 3
 (16.5-33)
0.27±0.89 1.16±0.55 0.70±0.40 8.83±4.95 12.32±4.97
Group 4
 (33-49.5)
0.26±0.80 1.25±0.53 0.76±0.37 10.19±5.96 12.48±5.52
Group 5
 (>50)
0.28±0.96 1.30±0.41 0.92±0.41 6.76±4.08 10.07±4.95
p 0.405 0.040* 0.063 0.213 0.427
*statistically significant differences among groups; p<0.05.
TMHk: tear meniscus height; Bulbar (BR) and limbal redness (LR) were graded automatically by K5M software; NIKBUT-FR: first rupture non-invasive 
Keratograph tear film break-up time; NIKBUT-AVG: average of non-invasive Keratograph tear film break-up time. 
Table 7. Relationship between MGL and the ocular surface parameters 
considering age as covariant.
                                               
*statistically significant; p<0.05.
(r, Spearman correlation coefficient) 
OSDI: The Ocular-surface-disease-index (scores); SPEED: Standard Patient Evaluation of Eye Dryness (scores). TMHk: 
tear meniscus height (mm); Bulbar and limbal redness (BR and LR) were graded automatically by K5M software; NIKBUT-
first: first rupture non-invasive Keratograph tear film break-up time (seconds); NIKBUT-avg: average of non-invasive 
Keratograph tear film break-up time (seconds). TFO: tear film osmolarity(mOsms/L); TBUT: tear break-up time (seconds); 
Schirmer test (mm); Corneal and conjunctival staining were graded using Oxford Staining Score System; MG: Meibomian 
glands
MGL
(Covariant: Age)
Correlation
coefficient
p
DED Questionnaires
OSDI 0.011 0.914
SPEED 0.012 0.904
K5M Parameters
TMHk 0.059 0.563
BR -0.003 0.969
LR -0.044 0.668
NIKBUT-fr -0.095 0.345
NIKBUT-avg -0.054 0.597
Classical Clinical Parameters
TFO 0.088 0.393
Corneal 
staining
0.208 0.041*
Conjunctival
staining
-0.004 0.966
TBUT -0.163 0.112
Schirmer test -0.065 0.527
MG features
MG quality 
secretion
0.044 0.587
